Dopamine D3 receptor gene variants and substance abuse in schizophrenia

Molecular Psychiatry

Volumn 3, Issue 4, 1998, Pages 337-341

  Krebs, M O ^a   Sautel, F ^b   Bourdel, M C ^a   Sokoloff, P ^b   Schwartz, J C ^b   Olie J P ^a   Loo H ^a   Poirier, M F ^a  

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

^b U de Neurobiologie et Pharmacol M   (France)

Author keywords

Association study; Comorbidity; Drug abuse; Drug dependence; Schizophrenia

Indexed keywords

DOPAMINE 3 RECEPTOR; DOPAMINE 2 RECEPTOR; DRD3 PROTEIN, HUMAN; ENDODEOXYRIBONUCLEASE BALI; PSYCHOTROPIC AGENT; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE;

ADULT; ARTICLE; CAUCASIAN; COMORBIDITY; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG DEPENDENCE; FEMALE; GENETIC POLYMORPHISM; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; SCHIZOPHRENIA; ADDICTION; COMPARATIVE STUDY; FRANCE; GENETIC VARIABILITY; GENETICS; GENOTYPE; HOMOZYGOTE; PSYCHOSIS; REFERENCE VALUE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

COMORBIDITY; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FRANCE; GENOTYPE; HOMOZYGOTE; HUMANS; MALE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PSYCHOTIC DISORDERS; PSYCHOTROPIC DRUGS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; REFERENCE VALUES; SCHIZOPHRENIA; SUBSTANCE-RELATED DISORDERS; VARIATION (GENETICS);

EID: 0031596019     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000411     Document Type: Article

References (31)

1. 3) as a target for neuroleptics. Nature 1990; 347: 146-151.
2. 3 receptors and use of antipsychotics in patients with schizophrenia. Arch Gen Psychiatry 1997; 54: 225-232.
3. 3 receptor gene. J Med Genet 1992; 29: 858-860.
4. Karayiorgou M, Gogos JA. Dissecting the genetic complexity of schizophrenia. Mol Psychiatry 1997; 2: 221-223.
5. Regier DA, Farmer ME, Rae DS. Comorbidity of mental disorders with alcohol and other drug abuse - Results from the epidemiologic catchment area (EGA) study. JAMA 1990; 264: 2511-2518.
6. Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 1994; 51: 273-279.
7. Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 1988; 85: 5274-5278.
8. Caine SB, Koob GF, Parsons LH, Everitt BJ, Schwartz J-C, Sokoloff P. D3 receptor functional test in vitro predicts potencies of dopamine agonists to reduce cocaine self-administration. Neuroreport 1997; 8: 2373-2377.
9. 3 receptor agonists partially reproduce the discriminative stimulus effects of cocaine in squirrel monkeys. J Phamacol Exp Ther 1996; 278: 1128-1137.
10. 3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J Neurosci 1996; 16: 6100-6106.
11. Cadoret RJ, Yates WR, Troughton E, Woodworth G, Stewart MA. Adoption studies demonstrating two genetic pathways to drug abuse. Arch Gen Psychiatry 1995; 52: 42-52.
12. 3 receptor polymorphism and alcohol dependence. Biol Psychiatry 1997; 42: 33S.
13. 3 receptor genes in alcohol dependence. Psychiatric Genet 1995; 5: 171-176.
14. 3 dopamine receptor gene in three independent samples. Am J Med Genet 1995; 60: 529-531.
15. 3 receptor gene associated with opiate dependence. Mol Psychiatry 1998; 3: 333-336.
16. Dubertret C, Gorwood P, Ades J, Feingold J, Schwartz J-C, Sokoloff P. A meta-analysis of DRD3 gene and schizophrenia: ethnic heterogeneity and significant association in Caucasians. Am J Med Genet [Neuropsychatric Genetics] 1998; (in press).
17. 3 receptor gene in schizophrenia. Acta Psychiatr Scand 1993; 87: 345-347.
18. 3 receptor gene locus in two independent samples. Am J Med Genet [Neuropsychiatric Genetics] 1996; 67: 505-514.
19. 3 dopamine receptor (DRD3) alleles and cocaine dependence. Addiction Biology 1996; 1: 281-287.
20. 3 receptor gene and schizophrenia. Am J Med Genet 1994; 54: 21-26.
21. 3 receptor gene polymorphisms: probable effects of family history of schizophrenia? Am J Med Gen [Neuropsychiatric Genetics] 1993; 48: 214-217.
22. 3 dopamine receptor. Am J Med Genet [Neuropsychiatric Genetics] 1993; 48: 83-86.
23. 3 receptor gene: organization, transcript variants and polymorphism associated with schizophrenia. Am J Med Genet [Neuropsychiatric Genetics] 1996; 67: 58-70.
24. 4) receptors in schizophrenia. Biol Psychiatry 1996; 40: 1209-1217.
25. 3 dopamine receptor Msc I polymorphism with schizophrenia. Am J Med Genet [Neuropsychiatric Genetics] 1996; 67: 455-458.
26. 3 receptor gene in schizophrenic patients. Neurosci Lett 1996; 220: 151-154.
27. May PR, Dencker SJ, Hubbard JW, Midha KK, Liberman RP. A systematic approach to treatment resistance in schizophrenic disorders. In: Dencker SJ, Kulhanel F (eds). Treatment Resistance in Schizophrenia. Vieweg Verlag: Wiesbaden, 1988.
28. Palmer MS, Dryden AJ, Hughes JT, Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 1991; 352: 340-342.
29. Endicott J, Spitzer RL. A diagnostic interview: a schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 1978; 35: 837-844.
30. Kay SR, Fiszbein A, Opler LA. The positive and negative symptom scale (PANSS). Schizophr Bull 1987; 13: 261-276.
31. 3 receptor as a useful polymorphism for investigating psychiatric disorders. Psychiatric Genet 1992; 2: 249-256.